Short-Term Debt to Capital: InfuSystem Holdings (INFU)

Corporate company logo of InfuSystem (INFU)

InfuSystem Holdings (INFU) generates revenue through the leasing and servicing of oncology drug delivery systems. This price chart illustrates the asset's performance, where the indicator stands at 0.04. The business implements smart pumps with electronic dosing to minimize manual labor for physicians. Due to its independence from global markets and the demand for medical technology, InfuSystem Holdings (INFU) serves as a resilient defensive asset.

INFU - InfuSystem Holdings Short-Term Debt to Capital Coefficient over the range 07/04/2022 - 10/30/2026

Analytical breakdowns for InfuSystem Holdings

- stock quotes and analyst forecast:
Stock Price InfuSystem Holdings|INFU - Average Forecast Price
- company stock exchange capitalization indicators:
Market Capitalization InfuSystem|INFU - Business Value
- book capitalization information:
Book Value per Share InfuSystem Holdings|INFU - Book Valuation of Business|Market Capitalization to Book Value Ratio infusystem.com|INFU - Cumulative Company Assets
- business debt structure and liquidity details:
Total Debt to Capital InfuSystem Holdings|INFU - Long-Term Debt to Capital|Short-Term Debt to Equity InfuSystem Holdings|INFU - Company Debts|Debt to Book Value InfuSystem|INFU - Company Long-Term Loans and Borrowings|Company Short-Term Debts InfuSystem Holdings|Quick Liquidity infusystem.com
- earnings and market ratios statistics:
INFU - Company Profit
General company analysis:InfuSystem Holdings, Inc. INFU
Brand item of InfuSystem Holdings

Drug dosing automation within InfuSystem Holdings (INFU) systems reduces staff workload, optimizing operational cycles. This indicator compares obligations with maturities of up to one year against equity, reflecting the current debt load. By analyzing the history of short-term borrowed capital to equity, an investor can observe liquidity trends and the risk of stagnant expansion. A decrease in this ratio confirms financial stability, which positively impacts the stability of share prices.

Direct competitors

Short-Term Debt to Capital ISRG|DHR - Current Liabilities to Capital|Short-Term Debt to Capital BDX (Becton Dickinson & Co)|STE: Short-Term Debt to Capital Ratio|West Pharmaceutical Services, Inc. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Baxter International Inc. BAX|MASI: Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Stevanato Group Corp|TFX (Teleflex Incorporated) - Short-Term Debt to Capital|Short-Term Debt to Capital merit.com|Short-Term Debt to Equity Envista (NVST)|Short-Term Debt to Equity ICUI (ICU Medical Inc)|Dentsply - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital LMAT|AtriCure, Inc. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient staar.com STAA|Niagen (NAGE) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio ZIMV|Short-Term Debt to Equity AngioDynamics Corp|Cerus Inc (CERS) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio TKNO (Alpha Teknova, Inc.)|Short-Term Loans to Capital Ratio MGRM|Short-Term Debt to Equity Sharps Technology STSS|Ratio of Short-Term Indebtedness to Capital UTMD|KRMD: Short-Term Debt to Equity Ratio|NYXH - Short-Term Debt to Capital|Microbot Medical Inc. (MBOT) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio pro-dex.com|ZTEK (Zentek) - Short-Term Debt to Capital|Current Liabilities to Capital Elutia Inc ELUT|Short-Term Debt to Equity Milestone Scientific Corp (MLSS)|NEXGEL Inc - Short-Term Debt to Capital Ratio|Retractable Technologies, Inc. - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio HBIO (Harvard Bioscience Inc.)|FEMY - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient MeihuaMed MHUA|POAI: Short-Term Debt to Capital|CJMB - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Atrion Corporation|Short-Term Debt to Capital Ratio NURO (neurometrix.com)